Reference: Riemersma, K. K., Haddock, L. A. III, Wilson, N. A., Minor, N., Eickhoff, J., Grogan, B. E., Kita-Yarbro, A., Halfmann, P. J., Segaloff, H. E., Kocharian, A., Florek, K. R., Westergaard, R., Bateman, A., Jeppson, G. E., Kawaoka, Y., O’Connor, D. H., Friedrich, T. C., & Grande, K. M. (2022). Shedding of infectious SARS-CoV-2 […]
Reference: South African National Department of Health. (2021). Rapid review of Ivermectin for COVID-19: Evidence review of clinical benefits and harms (Update: 30 July 2021). Summary: The South African National Department of Health conducted a rapid review to assess the efficacy of ivermectin in treating COVID-19. The review, which synthesised findings from multiple randomised controlled
Reference: Tareq, A. M., Bin Emran, T., Dhama, K., Dhawan, M., & Tallei, T. E. (2021). Impact of SARS-CoV-2 delta variant (B.1.617.2) in surging second wave of COVID-19 and efficacy of vaccines in tackling the ongoing pandemic. Human Vaccines & Immunotherapeutics, 17(11), 4126–4127. https://doi.org/10.1080/21645515.2021.1963601 Summary: The article examines the impact of the SARS-CoV-2 delta variant
Summary The document, authored by Dr. Herman J. Edeling, outlines positive developments in COVID-19 prevention and treatment as of July 2021. It emphasises the availability of effective, safe, and affordable preventive measures such as nutraceuticals (Vitamin D3, Zinc, Vitamin C, Quercetin, Melatonin) and the anti-infective agent Ivermectin. For symptomatic individuals, early home-based treatments including increased
Reference: Search results obtained to compile a database of all the studies done on Ivermecting as therapeutic drug for COVID-19. 2021-07-18. Summary: Database of all Ivermectin COVID-19 studies. 101 studies, 66 peer reviewed, 60 with results comparing treatment and control groups. DOWNLOAD
Reference: Brosh-Nissimov, T. et al. (2021). BNT162b2 vaccine breakthrough: clinical characteristics of 152 fully-vaccinated hospitalized COVID-19 patients in Israel. Clinical Microbiology and Infection. https://doi.org/10.1016/j.cmi.2021.06.036 Summary: A study conducted in Israel examined breakthrough infections in fully-vaccinated patients who were hospitalised with COVID-19. Out of 152 patients, 40% were immunocompromised, and the study revealed that despite the
Reference: Okahandja Community Forum. (2021, July 9). An Okahandja community project: What you can do at home. Summary: The Okahandja community project, initiated on 9 July 2021, provides guidance for individuals on how to manage health concerns related to Covid-19. Emphasising the importance of prevention and patient support, the document outlines necessary hygiene measures, such
Reference: Benn, C. S., & Aaby, P. (2021). Should COVID-19 be a vaccine disease or a childhood disease? The BMJ, 374, n1687. https://doi.org/10.1136/bmj.n1687 Summary: The article discusses the implications of COVID-19 vaccination for children, highlighting concerns over the safety and necessity of such measures. It critiques the small sample size of the Pfizer phase 3
Reference: Wucher, M. (2021). COVID-19 – Ask your doctor: What you should know today. Retrieved from [source link] Summary: Dr Martin Wucher’s guide offers critical insights into managing COVID-19, emphasising the importance of immune system readiness before, during, and after infection. He advises against self-medication and promotes seeking professional medical advice. The guide underscores the
Summary Dr. Herman J. Edeling’s article “COVID-19 – Blind Faith or Open Minds” addresses the confusion and polarisation surrounding expert opinions on the pandemic. He contrasts “fashionable opinions” from well-funded entities like politicians and media with “unfashionable opinions” from independent experts. Emphasising critical thinking, he advocates for transparent and reasoned debate. Edeling highlights the importance